Clinical outcomes in heart failure: Report from a community hospital-based registry

American Journal of Medicine

Volumn 107, Issue 6, 1999, Pages 549-555

  Philbin, Edward F ^a   Rocco Jr , Thomas A ^b   Lindenmuth, Norman W ^c   Ulrich, Kathleen ^d   Jenkins, Paul L ^e  

^a HENRY FORD HOSPITAL   (United States)

^b UNITY HEALTH SYSTEM   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Faxton Hospital   (United States)

^e BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; NITRATE; VASODILATOR AGENT; WARFARIN;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; NEW YORK; PATIENT READMISSION; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032785878     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00309-5     Document Type: Article

References (36)

1. O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States time for a different approach . J Heart Lung Transplant. 13:1994;S107-S112.
2. Domanski M.J., Garg R., Yusuf S. Prognosis in congestive heart failure. Hosenpud J.D., Greenberg B.H. Congestive Heart Failure Pathophysiology, Diagnosis and Comprehensive Approach to Management . 1994;622-627 Springer-Verlag, New York.
3. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure the Framingham study . J Am Coll Cardiol. 22:(suppl A):1993;6A-13A.
4. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. NEJM. 334:1996;1349-1355.
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial . Lancet. 353:1999;9-13.
6. Heidenreich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure a meta-analysis of randomized clinical trials . J Am Coll Cardiol. 30:1997;27-34.
7. The effect of digoxin on mortality and morbidity in patients with heart failure. NEJM. 336:1997;525-533.
8. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEJM. 325:1991;293-302.
9. Pitt B., Segal R., Martinez F.A., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 349:1997;747-752.
10. Philbin EF, McCullough PA, Polanczyk CA, et al. Are subjects in heart failure trials similar to patients in clinical practice? Circulation 1998;98(suppl I):I-866. Abstract.
11. Philbin E.F., Lynch L.J., Rocco T.A., et al. Does quality improvement work? The Management to Improve Survival in Congestive Heart Failure (MISCHF) study. Jt Comm J Qual Improv. 22:1996;721-733.
12. U.S. Health Care Financing Administration. Diagnosis Related Groups Definitions Manual. Wallingford, Conn: 3M Health Information Services; 1993.
13. Criteria Committee, New York Heart Association, Inc. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis. 6th ed. Boston: Little, Brown and Company; 1964:114.
14. Brophy J.M., DesLauriers G., Boucher B., Rouleau J.L. The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 9:1993;219-224.
15. Mohan P., Hii J.T., Wuttke R.D., et al. Acute heart failure determinants of outcome . Int J Cardiol. 32:1991;365-376.
16. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 87:(suppl VI):1993;VI-5-VI-16.
17. Gradman A.H., Deedwania P.C. Predictors of mortality in patients with heart failure. Card Clin. 12:1994;25-35.
18. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies development and validation . J Chron Dis. 40:1987;373-383.
19. Girman C.J., Kolman C., Liss C.L., et al. Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hypertrophy. Prostate. 29:1996;83-90.
20. Konstam MA, Dracup K, Bottoroff MB, et al. Quick Reference Guide for Clinicians No. 11. Heart Failure: Management of Patients with Left Ventricular Systolic Dysfunction. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, United States Department of Health and Human Services; AHCPR Publication No. 94-0613, 1994.
21. Williams J.F., Bristow M.R., Fowler M.B., et al. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. 92:1995;2764-2784.
22. Philbin E.F., DiSalvo T.G. The influence of race and gender on process of care, resource utilization, and hospital-based outcomes in congestive heart failure. Am J Cardiol. 82:1998;76-81.
23. Philbin E.F. Comprehensive multidisciplinary programs for management of patients with congestive heart failure. J Gen Intern Med. 14:1999;130-135.
24. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community. A study of all incident cases in Olmstead County, Minnesota, in 1991. Circulation. 98:1998;2282-2289.
25. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study . NEJM. 316:1987;1429-1435.
26. Zannand F., Briancon S., Juilliere Y., et al. Incidence, clinical and etiologic features and outcomes of advanced chronic heart failure the EPICAL Study . J Am Coll Cardiol. 33:1999;734-742.
27. Stevenson W.G., Stevenson L.W., Middlekauf H.R., et al. Improving survival for patients with advanced heart failure a study of 737 consecutive patients . J Am Coll Cardiol. 26:1995;1417-1423.
28. Pernenkil R., Vinson J.M., Shah A.S., et al. Course and prognosis in patients >70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol. 79:1997;216-219.
29. Krumholz H.M., Parent E.M., Tu N., et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 157:1997;99-104.
30. Philbin E.F., DiSalvo T.G. Managed care for congestive heart failure influence of payor status on process of care, resource utilization and clinical outcomes . Am Heart J. 136:1998;553-561.
31. Ashton C.M., Kuykendall D.H., Johnson M.L., et al. The association between the quality of inpatient care and early readmission. Ann Intern Med. 122:1995;415-421.
32. Rubenstein L.V., Kahn K.L., Reinisch E.J., et al. Changes in quality of care for five diseases measured by implicit review, 1981 to 1986. JAMA. 264:1990;1974-1979.
33. Philbin E.F., Rocco T.A. The utility of angiotensin-converting enzyme inhibitors in heart failure with preserved systolic function. Am Heart J. 134:1997;188-195.
34. Packer M, Poole-Wilson P, Armstrong P, et al. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic heart failure: the Assessment of Treatment with Lisinopril And Survival study (ATLAS). Eur Heart J 1998;19(suppl):142. Abstract.
35. Lechat P., Packer M., Chalon S., et al. Clinical effects of beta-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 98:1998;1184-1191.
36. Exner D.V., Dries D.L., Waclawiw M.A., et al. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction a post hoc analysis of the Studies of Left Ventricular Dysfunction . J Am Coll Cardiol. 33:1999;916-923.